Stocktoria
Fortrea Holdings Inc. FTRE
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2023-06-16
Chart by TradingView
3/9
Piotroski F — financial health
-3.58
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $2.7B | $2.7B | $2.8B | $2.8B |
| Operating income | -$872.6M | -$161.9M | $32.0M | $187.1M |
| Net income | -$986.2M | -$328.5M | -$25.2M | $186.2M |
| Operating cash flow | $113.5M | $262.8M | $168.4M | $82.7M |
| Total assets | $2.7B | $3.6B | $4.3B | $4.3B |
| Total liabilities | $2.2B | $2.2B | $2.6B | $945.3M |
| Shareholders' equity | $563.5M | $1.4B | $1.7B | $3.3B |
| Ratios | ||||
| Operating margin | -32.0% | -6.0% | 1.1% | 6.6% |
| Net margin | -36.2% | -12.2% | -0.9% | 6.6% |
| Return on assets | -36.3% | -9.2% | -0.6% | 4.3% |
| Return on equity | -175.0% | -24.1% | -1.5% | 5.6% |
| Debt / equity | 1.86× | 0.77× | 0.91× | 0.00× |
| Current ratio | 0.98 | 1.00 | 1.61 | 1.78 |
| Revenue growth | 1.0% | -5.1% | 0.2% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,432,709 | $13.5M |
| Point72 Asset Management, L.P. | 352,372 | $3.3M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -3.58 (distress)
- Working capital / assets -0.006
- Retained earnings / assets -0.509
- EBIT / assets -0.321
- Equity / liabilities 0.262
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001965040 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.